Caroline Lascoux‐Combe

2.8k total citations
64 papers, 1.5k citations indexed

About

Caroline Lascoux‐Combe is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Caroline Lascoux‐Combe has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 41 papers in Hepatology and 28 papers in Infectious Diseases. Recurrent topics in Caroline Lascoux‐Combe's work include Hepatitis C virus research (41 papers), Hepatitis B Virus Studies (33 papers) and Liver Disease Diagnosis and Treatment (24 papers). Caroline Lascoux‐Combe is often cited by papers focused on Hepatitis C virus research (41 papers), Hepatitis B Virus Studies (33 papers) and Liver Disease Diagnosis and Treatment (24 papers). Caroline Lascoux‐Combe collaborates with scholars based in France, United States and United Kingdom. Caroline Lascoux‐Combe's co-authors include Karine Lacombe, Patrick Miailhes, Pierre‐Marie Girard, Jean‐Michel Molina, Anders Boyd, D. Séréni, Patrick Yéni, Fabien Zoulim, François Raffi and Virginie Gressin and has published in prestigious journals such as The Lancet, PLoS ONE and Hepatology.

In The Last Decade

Caroline Lascoux‐Combe

59 papers receiving 1.5k citations

Peers

Caroline Lascoux‐Combe
Eugenia Vispo Spain
Carolynne Schwarze‐Zander Germany
Anastasia Karafoulidou Greece
P. B. A. Kernoff United Kingdom
Robert H. Kauffmann Netherlands
Claire Rekacewicz France
Jean‐Jacques Lefrère France
J. Medraño Spain
Giorgio Antonucci Italy
R Lüthy Switzerland
Eugenia Vispo Spain
Caroline Lascoux‐Combe
Citations per year, relative to Caroline Lascoux‐Combe Caroline Lascoux‐Combe (= 1×) peers Eugenia Vispo

Countries citing papers authored by Caroline Lascoux‐Combe

Since Specialization
Citations

This map shows the geographic impact of Caroline Lascoux‐Combe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Lascoux‐Combe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Lascoux‐Combe more than expected).

Fields of papers citing papers by Caroline Lascoux‐Combe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Lascoux‐Combe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Lascoux‐Combe. The network helps show where Caroline Lascoux‐Combe may publish in the future.

Co-authorship network of co-authors of Caroline Lascoux‐Combe

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Lascoux‐Combe. A scholar is included among the top collaborators of Caroline Lascoux‐Combe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Lascoux‐Combe. Caroline Lascoux‐Combe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaix, Marie‐Laure, Karl Stéfic, Caroline Lascoux‐Combe, et al.. (2024). Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023. Journal of Medical Virology. 96(10). e29948–e29948. 3 indexed citations
2.
Merlet, Pascal, Georgios Sidéris, Nathalie De Castro, et al.. (2022). Cardiopathie ischémique silencieuse chez les patients sous ARV : prévalence et facteurs de risque. 1(2). S134–S135. 1 indexed citations
3.
Miailhes, Patrick, Caroline Lascoux‐Combe, Sarah Maylin, et al.. (2021). Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study. Journal of Antimicrobial Chemotherapy. 76(11). 3009–3019. 4 indexed citations
4.
Miailhes, Patrick, Caroline Lascoux‐Combe, Sarah Maylin, et al.. (2021). Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus–Hepatitis B Virus–Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort. Clinical Infectious Diseases. 74(6). 1012–1021. 4 indexed citations
5.
Ghosn, Jade, Lambert Assoumou, Caroline Lascoux‐Combe, et al.. (2021). HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection. The Journal of Infectious Diseases. 225(1). 116–120. 4 indexed citations
6.
Armero, Alix, Maud Salmona, Nadia Mahjoub, et al.. (2020). Characterization of HIV-1 diversity in various compartments at the time of primary infection by ultradeep sequencing. Scientific Reports. 10(1). 2409–2409. 3 indexed citations
7.
Boyd, Anders, Karine Lacombe, Fabien Lavocat, et al.. (2017). Low incidence of precore W28* mutant variants in treated hepatitis B virus and human immunodeficiency virus co-infected patients. Antiviral Research. 149. 174–178. 3 indexed citations
8.
Iordache, L., Djaouïda Bengoufa, Olivier Tauléra, et al.. (2017). Nonorgan-specific autoantibodies in HIV-infected patients in the HAART era. Medicine. 96(10). e6230–e6230. 19 indexed citations
9.
Boyd, Anders, Laëtitia Canini, Joël Gozlan, et al.. (2017). Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients. Journal of Clinical Virology. 95. 55–60. 4 indexed citations
10.
11.
Cuzin, Lise, Pierre Delobel, Jacques Reynes, et al.. (2012). Maraviroc Intensification of Stable Antiviral Therapy in HIV-1–Infected Patients With Poor Immune Restoration. JAIDS Journal of Acquired Immune Deficiency Syndromes. 61(5). 557–564. 33 indexed citations
12.
13.
Winnock, María, Firouzé Bani‐Sadr, Élodie Pambrun, et al.. (2011). Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. Vaccine. 29(47). 8656–8660. 17 indexed citations
14.
Piroth, Lionel, Sophie Mahy, Stanislas Pol, et al.. (2011). Current management and recommendations on hepatitis B therapy in HIV-coinfected patients. Hepatology International. 7(2). 437–442. 4 indexed citations
15.
Sire, Jean-Marie, Muriel Vray, Jean‐Christophe Plantier, et al.. (2010). Comparative RNA Quantification of HIV-1 Group M and Non-M With the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR Assays. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(3). 239–243. 37 indexed citations
16.
Wendum, Dominique, Karine Lacombe, Marie Chevallier, et al.. (2009). Histological scoring of fibrosis and activity in HIV–chronic hepatitis B related liver disease: performance of the METAVIR score assessed on virtual slides. Journal of Clinical Pathology. 62(4). 361–363. 15 indexed citations
17.
Boyd, Anders, Karine Lacombe, Patrick Miailhes, et al.. (2009). Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. Journal of Viral Hepatitis. 17(1). 65–76. 30 indexed citations
18.
Sitbon, Olivier, Caroline Lascoux‐Combe, Jean‐François Delfraissy, et al.. (2007). Prevalence of HIV-Related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era. American Journal of Respiratory and Critical Care Medicine. 177(1). 108–113. 322 indexed citations
19.
Lacombe, Karine, Anders Boyd, Moı̈se Desvarieux, et al.. (2007). Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus. AIDS. 21(18). 2546–2549. 21 indexed citations
20.
Piroth, Lionel, D. Sène, Stanislas Pol, et al.. (2007). Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY). AIDS. 21(10). 1323–1331. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugenia Vispo Breakdown of academic impact, for papers by Carolynne Schwarze‐Zander Breakdown of academic impact, for papers by Anastasia Karafoulidou Breakdown of academic impact, for papers by P. B. A. Kernoff Breakdown of academic impact, for papers by Robert H. Kauffmann Breakdown of academic impact, for papers by Claire Rekacewicz Breakdown of academic impact, for papers by Jean‐Jacques Lefrère Breakdown of academic impact, for papers by J. Medraño Breakdown of academic impact, for papers by Giorgio Antonucci Breakdown of academic impact, for papers by R Lüthy
Rankless by CCL
2026